- $4.57m
- -$2.04m
- $42.30m
Annual balance sheet for C3is, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | 20-F | 20-F |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Short Term Investments | |||
| Cash and Short Term Investments | — | 9.06 | 12.6 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 0.822 | 10.4 | 2.82 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 1.02 | 20.3 | 16.3 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 38.8 | 75.2 | 84.1 |
| Total Assets | 39.9 | 95.5 | 100 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 0.965 | 39.9 | 18.7 |
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 0.965 | 39.9 | 29.1 |
| Non Redeemable Preferred Stock | |||
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | 38.9 | 55.5 | 71.4 |
| Total Liabilities & Shareholders' Equity | 39.9 | 95.5 | 100 |
| Total Common Shares Outstanding |